The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis

British Journal of Haematology

Volumn 94, Issue 1, 1996, Pages 76-81

  Joshua, Doug ^a   Petersen, Amarette ^a   Brown, Ross ^a   Pope, Belinda ^a   Snowdon, Leonie ^a   Gibson, John ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

CD38; CD45; Immature plasma cells; Labelling index; Multiple myeloma

Indexed keywords

CD38 ANTIGEN; CD45 ANTIGEN;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; LABELING INDEX; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030015735     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1784.x     Document Type: Article

References (21)

1. Boccadoro, M., Marmont, F., Tribalto, M., Fossati, G., Redoglia V., Battaglio, S., Massai, M., Gallamini A., Comotti, B. & Barbui, T. (1989) Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis. Journal of Clinical Oncology, 7, 119-125.
2. Brown, R.D., Ioannidis, R., Joshua, D.E. & Kronenberg, H. (1989) Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma. Australian and New Zealand Journal of Medicine, 19, 226-232.
3. Brown, R.D., Pope, B., Luo, X-F., Gibson, J. & Joshua, D.E. (1994) The oncoprotein phenotype of plasma cells from patients with multiple myeloma. Leukaemia and Lymphoma, 16, 147-156.
4. Drach, J., Gattringer, C., Glassel, H., Drach, D. & Huber, H. (1992) The biological and clinical significance of the KI-67 growth fraction in multiple myeloma. Haematological Oncology, 10, 125-134.
5. Durie, B.G., Russell, D.H. & Salmon, S.E. (1980) Reappraisal of plateau phase in myeloma. Lancet, ii. 65-67.
6. Girino, M., Riccardo, A., Luoni, R., Ucci, G. & Cuomo, A. (1991) Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies. Acta Haematologica. 85, 26-30.
7. Greipp, P.R., Lust, J.A., O'Fallon, W.M., Katzmann, J.A., Witzig, T.E. & Kyle, R.A. (1993) Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood, 81, 3382-3387.
8. Greipp, P.R., Katzmann, J.A. & Kyle, R.A. (1988) Value of beta 2-microglobulin level and plasma cells labelling indices as prognostic factors in patients with newly diagnosed myeloma. Blood, 72, 219-223.
9. Greipp, P.R. & Kyle, R.A. (1983) Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood, 62, 166-171.
10. Jensen, G.S., Mant, M.J., Belch, A.J., Berensen, J.R., Ruether, B.A. & Pilarsski, L.M. (1991) Selective expression of CD45 isoforms defines CALLA' monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood, 78, 711-719.
11. Joshua, D.E., Snowdon, L., Gibson, J., Hand, H., Brown, R., Warburton, P., Kulkarni, A., Vincent, P., Young, G., Gatenby, P., Basten, A. & Kronenberg, H. (1991) Multiple myeloma: plateau phase revisited. Haematology Reviews and Communications, 5, 59-66.
12. Kawano, M.M., Huang, N., Harada, H., Harada, Y., Sakai, A., Tanaka, H., Iwato, K. & Kuramoto, A. (1993) Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood, 82, 564-570.
13. Lohmann, R.C., Crawford, L.N. & Wood, D.E. (1994) Proficiency testing in reticulocyte counting. Clinical and Laboratory Haematology, 16, 57-64.
14. Omede, P., Boccadoro, M., Fusaro, A., Gallone, G. & Pileri, A. (1993) Multiple myeloma: 'early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics. British Journal of Haematology, 85, 504-513.
15. Overton, W.R. (1988) Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry, 9, 619-623.
16. Petersen, A.J., Brown, R.D., Pope, B.B., Jamieson, G.P., Paterson, A.R., Gibson, J., Wiley, J.S. & Joshua, D.E. (1994) Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation. Leukaemia and Lymphoma, 13, 491-499.
17. Pileri, A., Massaia, M., Diazani, U., Omede, P. & Boccadoro, M. (1987) Cytobiological studies in multiple myeloma. Acta Haematologica, 78, (Suppl. 1), 41-42.
18. Sailor, M., Vykoupil, K-F., Peest, D., Coldeway, R., Deicher, H. & Georgii, A. (1995) Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients. European Journal of Haematology, 54, 137-146.
19. San Miguel, J.F., Garcia-Sanz, R., Gonzalez, M., Moro, M.J., Hernandez, J.M., Ortega, F., Borrego, D., Carnero, M., Casanova, F., Jimemez, R., Portero, J.A. & Orfao, A. (1995) A new staging system for multiple myeloma based on the number of S phase plasma cells. Blood, 85, 448-455.
20. Schambeck, C.M., Wick, M., Bartl, R., Lamerz, A. & Fateh-Moghadam, A. (1995) Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase. Journal of Clinical Pathology, 48, 477-481.
21. Witzig, T.E., Gonchoroff, N.J., Katzmann, J.A., Therneau, T.M., Kyle, R.A. & Greipp, P.R. (1988) Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. Journal of Clinical Oncology, 6, 1041-1046.